"Clustered Regularly Interspaced
Short Palindromic Repeats."
The word "CRISPR" is an acronym that stands for "Clustered Regularly Interspaced
Short Palindromic Repeats." It was coined by Spanish microbiologist Francisco Mojica in the early 2000s. Mojica was studying the unique
DNA sequences he had discovered in certain bacteria.
The name "CRISPR" is descriptive of the key features of these
DNA sequences:
Clustered: The sequences are grouped together in clusters.
Regularly: They are found at regular intervals in the bacterial genome.
Interspaced: The repeating sequences are interspersed with unique
DNA sequences.
Short: The repeating sequences are relatively
short.
Palindromic Repeats: Some of these repeating sequences exhibit palindromic properties, meaning they read the same forwards and backward.
Mojica's discovery of these unique
DNA sequences laid the foundation for the development of the CRISPR-Cas gene-editing technology, which has since become a revolutionary tool in genetics and biotechnology. While Mojica coined the term "CRISPR" and made significant early contributions to the field, it was subsequent researchers, including Jennifer Doudna and Emmanuelle Charpentier, who adapted and applied CRISPR technology for precise gene editing, earning them the Nobel Prize in
Chemistry in
2020.
"Scientists are using CRISPR
technology to explore
potential treatments for genetic diseases by precisely editing the
DNA of affected individuals."
